latest news releases from the newsroom
PSAV Presentation Services
PSAV Gives Back to Veterans
CHICAGO, Dec. 1, 2015 (GLOBE NEWSWIRE) -- Last month, PSAV's Dallas/Fort Worth Regional Branch Office provided event technology support through their sponsorship of the American Airlines' Sky Ball XIII fundraiser event benefiting veterans, members of the military, Wounded Warriors and their families.
Accelerate Diagnostics, Inc.
Accelerate Diagnostics to Present at the 27th Annual Piper Jaffray Healthcare Conference on December 2, 2015
TUCSON, Ariz., Dec. 1, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) announced today that Lawrence Mehren, Chief Executive Officer, is scheduled to present a corporate update at the Piper Jaffray Healthcare Conference in New York City, NY on Wednesday, December 2nd at 12:30 PM ET.
SCYNEXIS, Inc. Initiates Enrollment of the Phase 2 Study of SCY-078 in Vulvovaginal Candidiasis
JERSEY CITY, N.J., Dec. 1, 2015 (GLOBE NEWSWIRE) -- Drug development company SCYNEXIS, Inc. (Nasdaq:SCYX) today announced that it has initiated enrollment and the first group of patients have been dosed in its Phase 2 study of oral SCY-078 as a treatment for vulvovaginal candidiasis (VVC). SCY-078, SCYNEXIS' novel antifungal drug candidate, is an oral glucan synthase inhibitor and is also in development as both oral and intravenous formulations for the treatment of invasive and life-threatening fungal infections.